...
首页> 外文期刊>Acta nephrologica >Postoperative Acute Kidney Injury among Patients with Chronic Kidney Disease: Comparisons between the AKIN and KDIGO Creatinine Criteria in Diagnosis and Prognosis
【24h】

Postoperative Acute Kidney Injury among Patients with Chronic Kidney Disease: Comparisons between the AKIN and KDIGO Creatinine Criteria in Diagnosis and Prognosis

机译:慢性肾脏病患者的术后急性肾脏损伤:AKIN和KDIGO肌酐标准在诊断和预后方面的比较

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: This retrospective study determines whether the Kidney Disease: Improving Global Outcomes (KDIGO) creatinine criteria are superior to Acute Kidney Injury Network (AKIN) creatinine criteria in detecting non-dialysis Acute Kidney Injury (AKI) events and predicting mortality in chronic kidney disease (CKD) patients after surgery. METHODS: Surgical patients who were admitted to the intensive care unit were enrolled. Non-dialysis AKI cases were defined using either KDIGO or AKIN creatinine criteria and stratified by CKD stages. The adjusted hazard ratios (AHRs) for in-hospital mortality are compared to those without AKI. The cumulative survival curves and the predictability for mortality are accessed by Kaplan-Meier method and calculating the area under the curve (AUC) for the receiver operating characteristic curve (ROC), respectively. RESULTS: From a total of 771 postoperative patients, the overall in-hospital mortality rate was 16.2% (125 cases) and that for AKI according to KDIGO and AKIN creatinine criteria was 23.5% (181 cases) and 22.7% (175 cases), respectively. The cumulative survival curve stratified by CKD and AKI stages were comparable between KDIGO and AKIN creatinine criteria. The discriminative power for mortality stratified by CKD stages for KDIGO and AKIN creatinine criteria are as followed: all subjects, 0.673 vs. 0.658; non CKD, 0.866 vs. 0.822; early stage CKD: 0.725 vs. 0.711; late stage CKD: 0.645 vs. 0.629 (all Ps < 0.001, except in late stage CKD (P = 0.013 vs. 0.030)). CONCLUSION: The KDIGO creatinine criteria is superior to AKIN creatinine criteria in predicting mortality and detecting non-dialysis AKI events after surgery, even in those with advanced CKD.
机译:目的:这项回顾性研究确定了肾脏疾病:改善全球结局(KDIGO)肌酐标准在检测非透析急性肾脏损伤(AKI)事件和预测慢性肾脏病死亡率方面是否优于急性肾损伤网(AKIN)肌酐标准。 (CKD)术后的患者。方法:招收重症监护病房的外科手术患者。使用KDIGO或AKIN肌酐标准定义非透析性AKI病例,并按CKD分期进行分层。将经过调整的院内死亡率危险比(AHRs)与没有AKI的危险比进行比较。累积生存曲线和死亡率可预测性通过Kaplan-Meier方法访问,并分别针对接收器工作特征曲线(ROC)计算曲线下面积(AUC)。结果:在总共771例术后患者中,根据KDIGO和AKIN肌酐标准,AKI的总体住院死亡率为16.2%(125例),AKI的总体住院死亡率为23.5%(181例)和22.7%(175例),分别。 CKD和AKI阶段分层的累积生存曲线在KDIGO和AKIN肌酐标准之间是可比的。 CKDGO和AKIN肌酐标准按CKD分期分层的死亡率判别能力如下:所有受试者,分别为0.673和0.658;非CKD,0.866和0.822;早期CKD:0.725和0.711;晚期CKD:0.645 vs. 0.629(所有Ps <0.001,后期CKD除外(P = 0.013 vs. 0.030))。结论:KDIGO肌酐标准在预测死亡率和检测术后非透析性AKI事件方面优于AKIN肌酐标准,即使在患有CKD的患者中也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号